These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. MicroRNA-630 suppresses tumor metastasis through the TGF-β- miR-630-Slug signaling pathway and correlates inversely with poor prognosis in hepatocellular carcinoma. Chen WX; Zhang ZG; Ding ZY; Liang HF; Song J; Tan XL; Wu JJ; Li GZ; Zeng Z; Zhang BX; Chen XP Oncotarget; 2016 Apr; 7(16):22674-86. PubMed ID: 26993767 [TBL] [Abstract][Full Text] [Related]
7. Combined treatment with zingerone and its novel derivative synergistically inhibits TGF-β1 induced epithelial-mesenchymal transition, migration and invasion of human hepatocellular carcinoma cells. Kim YJ; Jeon Y; Kim T; Lim WC; Ham J; Park YN; Kim TJ; Ko H Bioorg Med Chem Lett; 2017 Feb; 27(4):1081-1088. PubMed ID: 28110870 [TBL] [Abstract][Full Text] [Related]
8. Higher matrix stiffness as an independent initiator triggers epithelial-mesenchymal transition and facilitates HCC metastasis. Dong Y; Zheng Q; Wang Z; Lin X; You Y; Wu S; Wang Y; Hu C; Xie X; Chen J; Gao D; Zhao Y; Wu W; Liu Y; Ren Z; Chen R; Cui J J Hematol Oncol; 2019 Nov; 12(1):112. PubMed ID: 31703598 [TBL] [Abstract][Full Text] [Related]
9. TGF-β as Multifaceted Orchestrator in HCC Progression: Signaling, EMT, Immune Microenvironment, and Novel Therapeutic Perspectives. Dituri F; Mancarella S; Cigliano A; Chieti A; Giannelli G Semin Liver Dis; 2019 Feb; 39(1):53-69. PubMed ID: 30586675 [TBL] [Abstract][Full Text] [Related]
10. miR-4458 inhibits the epithelial-mesenchymal transition of hepatocellular carcinoma cells by suppressing the TGF-β signaling pathway via targeting TGFBR1. Zhang Y; Shi K; Liu H; Chen W; Luo Y; Wei X; Wu Z Acta Biochim Biophys Sin (Shanghai); 2020 May; 52(5):554-562. PubMed ID: 32324847 [TBL] [Abstract][Full Text] [Related]
11. TGF-β signaling and epithelial-mesenchymal transition in cancer progression. Katsuno Y; Lamouille S; Derynck R Curr Opin Oncol; 2013 Jan; 25(1):76-84. PubMed ID: 23197193 [TBL] [Abstract][Full Text] [Related]
12. GP73 promotes epithelial-mesenchymal transition and invasion partly by activating TGF-β1/Smad2 signaling in hepatocellular carcinoma. Yang Y; Liu Q; Li Z; Zhang R; Jia C; Yang Z; Zhao H; Ya S; Mao R; Ailijiang T; Bao Y; Zhang H Carcinogenesis; 2018 Jul; 39(7):900-910. PubMed ID: 29365054 [TBL] [Abstract][Full Text] [Related]
13. Neuropilin-2 induced by transforming growth factor-β augments migration of hepatocellular carcinoma cells. Wittmann P; Grubinger M; Gröger C; Huber H; Sieghart W; Peck-Radosavljevic M; Mikulits W BMC Cancer; 2015 Nov; 15():909. PubMed ID: 26573807 [TBL] [Abstract][Full Text] [Related]
14. β-Arrestin1 is involved in hepatocellular carcinoma metastasis via extracellular signal-regulated kinase-mediated epithelial-mesenchymal transition. Xu X; Lei Y; Zhou H; Guo Y; Liu H; Jiang J; Yang Y; Wu B J Gastroenterol Hepatol; 2020 Dec; 35(12):2229-2240. PubMed ID: 32445259 [TBL] [Abstract][Full Text] [Related]
15. A fibrous stromal component in hepatocellular carcinoma reveals a cholangiocarcinoma-like gene expression trait and epithelial-mesenchymal transition. Seok JY; Na DC; Woo HG; Roncalli M; Kwon SM; Yoo JE; Ahn EY; Kim GI; Choi JS; Kim YB; Park YN Hepatology; 2012 Jun; 55(6):1776-86. PubMed ID: 22234953 [TBL] [Abstract][Full Text] [Related]
16. Axl activates autocrine transforming growth factor-β signaling in hepatocellular carcinoma. Reichl P; Dengler M; van Zijl F; Huber H; Führlinger G; Reichel C; Sieghart W; Peck-Radosavljevic M; Grubinger M; Mikulits W Hepatology; 2015 Mar; 61(3):930-41. PubMed ID: 25251599 [TBL] [Abstract][Full Text] [Related]
17. Disulfiram combined with copper inhibits metastasis and epithelial-mesenchymal transition in hepatocellular carcinoma through the NF-κB and TGF-β pathways. Li Y; Wang LH; Zhang HT; Wang YT; Liu S; Zhou WL; Yuan XZ; Li TY; Wu CF; Yang JY J Cell Mol Med; 2018 Jan; 22(1):439-451. PubMed ID: 29148232 [TBL] [Abstract][Full Text] [Related]
18. miR-181a mediates TGF-β-induced hepatocyte EMT and is dysregulated in cirrhosis and hepatocellular cancer. Brockhausen J; Tay SS; Grzelak CA; Bertolino P; Bowen DG; d'Avigdor WM; Teoh N; Pok S; Shackel N; Gamble JR; Vadas M; McCaughan GW Liver Int; 2015 Jan; 35(1):240-53. PubMed ID: 24576072 [TBL] [Abstract][Full Text] [Related]
19. Sanguinarine inhibits epithelial-mesenchymal transition via targeting HIF-1α/TGF-β feed-forward loop in hepatocellular carcinoma. Su Q; Fan M; Wang J; Ullah A; Ghauri MA; Dai B; Zhan Y; Zhang D; Zhang Y Cell Death Dis; 2019 Dec; 10(12):939. PubMed ID: 31819036 [TBL] [Abstract][Full Text] [Related]
20. Ubiquitin-specific protease 4 promotes metastasis of hepatocellular carcinoma by increasing TGF-β signaling-induced epithelial-mesenchymal transition. Qiu C; Liu Y; Mei Y; Zou M; Zhao Z; Ye M; Wu X Aging (Albany NY); 2018 Oct; 10(10):2783-2799. PubMed ID: 30335615 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]